MedPath

Investigating the effect of platelet-rich plasma in androgenetic alopecia

Phase 3
Recruiting
Conditions
Androgenetic alopecia.
Androgenic alopecia
Registration Number
IRCT20221230056991N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients willing to participate in the study
Confirmatory diagnosis of androgenetic alopecia disease by two experts with skin and hair experience
Women aged 18 to 60 years
Moderate to severe hair loss

Exclusion Criteria

Patients suffering from other types of alopecia (such as alopecia areata, telogen effluvium, anagen effluvium and scarring alopecias)
Patients with active psoriasis or active lichen planus due to the positive Köbner phenomenon in these diseases
Any serious systemic disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase density and thickness of hair. Timepoint: The beginning of the study and 6 months after the start of the study. Method of measurement: Trichogram, standard photography.
Secondary Outcome Measures
NameTimeMethod
Patient satisfaction score, doctor satisfaction score. Timepoint: The beginning of the study and 6 months after the start of the study. Method of measurement: A 10-point questionnaire is assigned for the patient's satisfaction, as well as a 10-point questionnaire that is completed by the doctor based on the comparison of the standard photography score and the comparison of the trichogram (checking the thickness and density of the hair).
© Copyright 2025. All Rights Reserved by MedPath